Shareholder information

Information for our shareholders, including significant shareholdings and advisors

Shareholder Information

Corporate Goverance

How we comply with the QCA code

Corporate Governance

Results, Reports and Presentations

View our latest releases

Latest reports

AIM Rule 26

Details required under Aim rule 26

AIM Rule 26

RNS alerts

07 Oct 2019 Interim Results
17 Sep 2019 Holding in Company
04 Sep 2019 Add'l Price Monitoring Extn.

Email alerts

Partnering & Collaboration

Our NDD approach consistently generates potent and novel hits, assisting companies increase the productivity of their drug discovery.

Please get in touch at